Your browser doesn't support javascript.
loading
Zoledronic acid for relapsed Langerhans cell histiocytosis with isolated skull bone lesion.
Kudo, Ko; Tanaka, Tatsuhiko; Kobayashi, Akie; Terui, Kiminori; Ito, Etsuro.
Affiliation
  • Kudo K; Department of Pediatrics, Hirosaki University School of Medicine, Hirosaki, Japan.
  • Tanaka T; Department of Pediatrics, Aomori Prefecture Hospital, Aomori, Japan.
  • Kobayashi A; Department of Pediatrics, Hirosaki University School of Medicine, Hirosaki, Japan.
  • Terui K; Department of Pediatrics, Hirosaki University School of Medicine, Hirosaki, Japan.
  • Ito E; Department of Pediatrics, Hirosaki University School of Medicine, Hirosaki, Japan.
Pediatr Int ; 61(3): 315-317, 2019 Mar.
Article in En | MEDLINE | ID: mdl-30793439
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Skull / Bone Diseases / Histiocytosis, Langerhans-Cell / Bone Density Conservation Agents / Zoledronic Acid Limits: Child / Female / Humans Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Skull / Bone Diseases / Histiocytosis, Langerhans-Cell / Bone Density Conservation Agents / Zoledronic Acid Limits: Child / Female / Humans Language: En Year: 2019 Type: Article